Animal Drug Compounding Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,995	192 Pages	Fairfield Market Research	July, 2025	FCSL20265109

Best Price Guarantee
Price	from $4,995
Length	192 Pages
Publisher	Fairfield Market Research
Published Date	July, 2025
SKU	FCSL20265109

Table of Contents
Description

The global animal drug compounding market is projected to witness steady expansion, with its value expected to reach approximately US$ 1.3 Bn in 2025 and grow to US$ 2.3 Bn by 2032. The market is anticipated to register a strong CAGR of 8.49% during the forecast period of 2025 to 2032. Growing demand for customized veterinary medications, increasing pet adoption, and the need for tailored dosage forms are key factors driving market growth.

Animal Drug Compounding Market – Report Scope:

The animal drug compounding market involves the creation of personalized medications for animals when FDA-approved drugs are unavailable or unsuitable. These compounded drugs are designed to meet the specific medical needs of individual animals, particularly in cases of allergies, dosage alterations, or unique delivery methods. With rising awareness among pet owners and veterinarians about tailored therapies, the demand for compounding services is rising. The market also benefits from the increasing aging pet population, advancements in veterinary healthcare, and expansion of compounding pharmacies.

Key Market Drivers:

The growth of the global animal drug compounding market is primarily driven by rising pet ownership and increasing awareness of animal health. As more pet owners seek individualized treatments for their animals, compounded drugs offer solutions that address specific needs, such as palatable flavors and alternative formulations. Additionally, shortages of certain veterinary drugs and the need for dosage adjustments according to species, size, and medical condition fuel demand. Veterinarians are increasingly recommending compounded medications for chronic illnesses, pain management, and hormonal imbalances. Regulatory support for compounded drug usage in veterinary medicine is also facilitating market expansion.

Market Restraints:

Despite its growing appeal, the animal drug compounding market faces notable restraints. A lack of standardized regulations across countries poses a compliance challenge for manufacturers and pharmacies. Quality assurance and consistency in formulations can also be difficult to maintain, potentially affecting treatment outcomes. Moreover, high operational costs associated with compounding facilities and the need for specialized pharmacists may limit the scalability of smaller players. Limited insurance coverage for compounded veterinary drugs can also discourage some pet owners from choosing these customized options.

Emerging Business Opportunities:

The expanding role of personalized medicine in veterinary care presents significant opportunities for players in the animal drug compounding market. Increasing acceptance of pet humanization and the premiumization of pet care are propelling demand for high-quality and convenient treatment options. Compounding pharmacies can leverage technological advancements to improve formulations and delivery systems. There is also scope for expansion in emerging markets such as Asia Pacific and Latin America, where veterinary infrastructure is developing rapidly. Collaborations with veterinary clinics, hospitals, and academic institutions may further strengthen R&D and commercialization efforts.

Regional Outlook:

North America currently dominates the global animal drug compounding market, owing to its well-established veterinary healthcare infrastructure, high pet ownership rates, and favorable regulatory environment. The United States, in particular, accounts for a significant share due to the presence of leading compounding pharmacies and strong demand for tailored veterinary care. Europe is also witnessing notable growth, driven by increased spending on companion animals and innovations in compounding techniques. Meanwhile, Asia Pacific is emerging as a high-potential region due to rising pet adoption, expanding veterinary services, and growing awareness about animal health in countries like China, India, and Australia.

Leading Companies:

Prominent players in the global animal drug compounding market include:
• Hoye's Pharmacy
• Vertisis Custom Pharmacy
• Smith Caldwell Drug Store
• Sixth Avenue Medical Pharmacy
• Dougherty's Pharmacy
• Triangle Compounding Pharmacy Inc.
• Medisca Inc.
• Wedgewood Pharmacy
• Millers Pharmacy
• Chiron Compounding Pharmacy
• MEDS Canadian Compounding Pharmacy
• Aurora Compounding
• Pace Pharmacy
• Victoria Compounding Pharmacy
• Pratt’s Compounding Pharmacy
• People’s Choice Pharmacy

These companies are focusing on expanding their compounding capabilities, ensuring regulatory compliance, and developing palatable and effective formulations to meet the growing demands of veterinarians and pet owners. Strategic partnerships, staff training, and investments in compounding automation are key strategies for competitive advantage.

Market Segmentation:

By Product:
• CNS Agents
• Anti-Infective Agents
• Hormones and Substitutes
• Anti-inflammatory Agents
• Others

By Animal:
• Companion

o Cats

o Dogs

o Others
• Livestock

By Formulation:
• Oral
• Injectable
• Others

By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Please note: Delivery Timelines - 5 working days.

1. Executive Summary: 1.1. Global Animal Drug Compounding Market Snapshot; 1.2. Future Projections; 1.3. Key Market Trends; 1.4. Regional Snapshot, by Value, 2023; 1.5. Analyst Recommendations
2. Market Overview: 2.1. Market Definitions and Segmentations; 2.2. Market Dynamics; 2.2.1. Drivers; 2.2.2. Restraints; 2.2.3. Market Opportunities; 2.3. Value Chain Analysis; 2.4. Porter’s Five Forces Analysis; 2.5. COVID-19 Impact Analysis; 2.5.1. Supply; 2.5.2. Demand; 2.6. Impact of Ukraine-Russia Conflict; 2.7. Economic Overview; 2.7.1. World Economic Projections; 2.8. PESTLE Analysis
3. Global Animal Drug Compounding Market Outlook, 2018 – 2031: 3.1. Global Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031; 3.1.1. Key Highlights; 3.1.1.1. CNS Agents; 3.1.1.2. Anti-Infective Agents; 3.1.1.3. Hormones and Substitutes; 3.1.1.4. Anti-inflammatory Agents; 3.1.1.5. Others; 3.2. Global Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031; 3.2.1. Key Highlights; 3.2.1.1. Companion Animal; 3.2.1.1.1. Cats; 3.2.1.1.2. Dogs; 3.2.1.1.3. Others; 3.2.1.2. Livestock Animals; 3.3. Global Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031; 3.3.1. Key Highlights; 3.3.1.1. Oral; 3.3.1.2. Injectable; 3.3.1.3. Others; 3.4. Global Animal Drug Compounding Market Outlook, by Region, Value (US$ Bn), 2018 – 2031; 3.4.1. Key Highlights; 3.4.1.1. North America; 3.4.1.2. Europe; 3.4.1.3. Asia Pacific; 3.4.1.4. Latin America; 3.4.1.5. Middle East & Africa
4. North America Animal Drug Compounding Market Outlook, 2018 – 2031: 4.1. North America Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031; 4.1.1. Key Highlights; 4.1.1.1. CNS Agents; 4.1.1.2. Anti-Infective Agents; 4.1.1.3. Hormones and Substitutes; 4.1.1.4. Anti-inflammatory Agents; 4.1.1.5. Others; 4.2. North America Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031; 4.2.1. Key Highlights; 4.2.1.1. Companion Animal; 4.2.1.1.1. Cats; 4.2.1.1.2. Dogs; 4.2.1.1.3. Others; 4.2.1.2. Livestock Animals; 4.3. North America Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031; 4.3.1. Key Highlights; 4.3.1.1. CNS Agents; 4.3.1.2. Anti-Infective Agents; 4.3.1.3. Hormones and Substitutes; 4.3.1.4. Anti-inflammatory Agents; 4.3.1.5. Others; 4.3.2. BPS Analysis/Market Attractiveness Analysis; 4.4. North America Animal Drug Compounding Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 4.4.1. Key Highlights; 4.4.1.1. U.S. Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 4.4.1.2. U.S. Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 4.4.1.3. U.S. Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 4.4.1.4. Canada Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 4.4.1.5. Canada Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 4.4.1.6. Canada Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Animal Drug Compounding Market Outlook, 2018 – 2031: 5.1. Europe Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031; 5.1.1. Key Highlights; 5.1.1.1. CNS Agents; 5.1.1.2. Anti-Infective Agents; 5.1.1.3. Hormones and Substitutes; 5.1.1.4. Anti-inflammatory Agents; 5.1.1.5. Others; 5.2. Europe Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031; 5.2.1. Key Highlights; 5.2.1.1. Companion Animal; 5.2.1.1.1. Cats; 5.2.1.1.2. Dogs; 5.2.1.1.3. Others; 5.2.1.2. Livestock Animals; 5.3. Europe Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031; 5.3.1. Key Highlights; 5.3.1.1. CNS Agents; 5.3.1.2. Anti-Infective Agents; 5.3.1.3. Hormones and Substitutes; 5.3.1.4. Anti-inflammatory Agents; 5.3.1.5. Others; 5.3.2. BPS Analysis/Market Attractiveness Analysis; 5.4. Europe Animal Drug Compounding Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 5.4.1. Key Highlights; 5.4.1.1. Germany Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 5.4.1.2. Germany Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 5.4.1.3. Germany Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 5.4.1.4. U.K. Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 5.4.1.5. U.K. Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 5.4.1.6. U.K. Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 5.4.1.7. France Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 5.4.1.8. France Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 5.4.1.9. France Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 5.4.1.10. Italy Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 5.4.1.11. Italy Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 5.4.1.12. Italy Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 5.4.1.13. Turkey Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 5.4.1.14. Turkey Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 5.4.1.15. Turkey Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 5.4.1.16. Russia Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 5.4.1.17. Russia Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 5.4.1.18. Russia Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 5.4.1.19. Rest of Europe Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 5.4.1.20. Rest of Europe Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 5.4.1.21. Rest of Europe Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Animal Drug Compounding Market Outlook, 2018 – 2031: 6.1. Asia Pacific Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031; 6.1.1. Key Highlights; 6.1.1.1. CNS Agents; 6.1.1.2. Anti-Infective Agents; 6.1.1.3. Hormones and Substitutes; 6.1.1.4. Anti-inflammatory Agents; 6.1.1.5. Others; 6.2. Asia Pacific Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031; 6.2.1. Key Highlights; 6.2.1.1. Companion Animal; 6.2.1.1.1. Cats; 6.2.1.1.2. Dogs; 6.2.1.1.3. Others; 6.2.1.2. Livestock Animals; 6.3. Asia Pacific Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031; 6.3.1. Key Highlights; 6.3.1.1. CNS Agents; 6.3.1.2. Anti-Infective Agents; 6.3.1.3. Hormones and Substitutes; 6.3.1.4. Anti-inflammatory Agents; 6.3.1.5. Others; 6.3.2. BPS Analysis/Market Attractiveness Analysis; 6.4. Asia Pacific Animal Drug Compounding Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 6.4.1. Key Highlights; 6.4.1.1. China Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 6.4.1.2. China Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 6.4.1.3. China Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 6.4.1.4. Japan Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 6.4.1.5. Japan Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 6.4.1.6. Japan Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 6.4.1.7. South Korea Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 6.4.1.8. South Korea Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 6.4.1.9. South Korea Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 6.4.1.10. India Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 6.4.1.11. India Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 6.4.1.12. India Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 6.4.1.13. Southeast Asia Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 6.4.1.14. Southeast Asia Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 6.4.1.15. Southeast Asia Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 6.4.1.16. Rest of Asia Pacific Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 6.4.1.17. Rest of Asia Pacific Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 6.4.1.18. Rest of Asia Pacific Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Animal Drug Compounding Market Outlook, 2018 – 2031: 7.1. Latin America Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031; 7.1.1. Key Highlights; 7.1.1.1. CNS Agents; 7.1.1.2. Anti-Infective Agents; 7.1.1.3. Hormones and Substitutes; 7.1.1.4. Anti-inflammatory Agents; 7.1.1.5. Others; 7.2. Latin America Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031; 7.2.1.1. Companion Animal; 7.2.1.1.1. Cats; 7.2.1.1.2. Dogs; 7.2.1.1.3. Others; 7.2.1.2. Livestock Animals; 7.3. Latin America Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031; 7.3.1. Key Highlights; 7.3.1.1. CNS Agents; 7.3.1.2. Anti-Infective Agents; 7.3.1.3. Hormones and Substitutes; 7.3.1.4. Anti-inflammatory Agents; 7.3.1.5. Others; 7.3.2. BPS Analysis/Market Attractiveness Analysis; 7.4. Latin America Animal Drug Compounding Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 7.4.1. Key Highlights; 7.4.1.1. Brazil Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 7.4.1.2. Brazil Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 7.4.1.3. Brazil Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 7.4.1.4. Mexico Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 7.4.1.5. Mexico Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 7.4.1.6. Mexico Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 7.4.1.7. Argentina Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 7.4.1.8. Argentina Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 7.4.1.9. Argentina Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 7.4.1.10. Rest of Latin America Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 7.4.1.11. Rest of Latin America Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 7.4.1.12. Rest of Latin America Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Animal Drug Compounding Market Outlook, 2018 – 2031: 8.1. Middle East & Africa Animal Drug Compounding Market Outlook, by Product, Value (US$ Bn), 2018 – 2031; 8.1.1. Key Highlights; 8.1.1.1. CNS Agents; 8.1.1.2. Anti-Infective Agents; 8.1.1.3. Hormones and Substitutes; 8.1.1.4. Anti-inflammatory Agents; 8.1.1.5. Others; 8.2. Middle East & Africa Animal Drug Compounding Market Outlook, by Animal, Value (US$ Bn), 2018 – 2031; 8.2.1. Key Highlights; 8.2.1.1. Companion Animal; 8.2.1.1.1. Cats; 8.2.1.1.2. Dogs; 8.2.1.1.3. Others; 8.2.1.2. Livestock Animals; 8.3. Middle East & Africa Animal Drug Compounding Market Outlook, by Formulation, Value (US$ Bn), 2018 – 2031; 8.3.1. Key Highlights; 8.3.1.1. CNS Agents; 8.3.1.2. Anti-Infective Agents; 8.3.1.3. Hormones and Substitutes; 8.3.1.4. Anti-inflammatory Agents; 8.3.1.5. Others; 8.3.2. BPS Analysis/Market Attractiveness Analysis; 8.4. Middle East & Africa Animal Drug Compounding Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 8.4.1. Key Highlights; 8.4.1.1. GCC Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 8.4.1.2. GCC Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 8.4.1.3. GCC Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 8.4.1.4. South Africa Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 8.4.1.5. South Africa Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 8.4.1.6. South Africa Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 8.4.1.7. Egypt Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 8.4.1.8. Egypt Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 8.4.1.9. Egypt Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 8.4.1.10. Nigeria Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 8.4.1.11. Nigeria Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 8.4.1.12. Nigeria Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 8.4.1.13. Rest of Middle East & Africa Animal Drug Compounding Market by Product, Value (US$ Bn), 2018 – 2031; 8.4.1.14. Rest of Middle East & Africa Animal Drug Compounding Market by Animal, Value (US$ Bn), 2018 – 2031; 8.4.1.15. Rest of Middle East & Africa Animal Drug Compounding Market by Formulation, Value (US$ Bn), 2018 – 2031; 8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape: 9.1. By Distribution Channel vs by Animal Heat map; 9.2. Manufacturer vs by Animal Heatmap; 9.3. Company Market Share Analysis, 2023; 9.4. Competitive Dashboard; 9.5. Company Profiles; 9.5.1. Hoye's Pharmacy; 9.5.1.1. Company Overview; 9.5.1.2. Product Portfolio; 9.5.1.3. Financial Overview; 9.5.1.4. Business Strategies and Development; 9.5.2. Vertisis Custom Pharmacy; 9.5.2.1. Company Overview; 9.5.2.2. Product Portfolio; 9.5.2.3. Financial Overview; 9.5.2.4. Business Strategies and Development; 9.5.3. Smith Caldwell Drug Store; 9.5.3.1. Company Overview; 9.5.3.2. Product Portfolio; 9.5.3.3. Financial Overview; 9.5.3.4. Business Strategies and Development; 9.5.4. Sixth Avenue Medical Pharmacy; 9.5.4.1. Company Overview; 9.5.4.2. Product Portfolio; 9.5.4.3. Financial Overview; 9.5.4.4. Business Strategies and Development; 9.5.5. Dougherty's Pharmacy; 9.5.5.1. Company Overview; 9.5.5.2. Product Portfolio; 9.5.5.3. Financial Overview; 9.5.5.4. Business Strategies and Development; 9.5.6. Triangle Compounding Pharmacy Inc.; 9.5.6.1. Company Overview; 9.5.6.2. Product Portfolio; 9.5.6.3. Financial Overview; 9.5.6.4. Business Strategies and Development; 9.5.7. Medisca Inc.; 9.5.7.1. Company Overview; 9.5.7.2. Product Portfolio; 9.5.7.3. Financial Overview; 9.5.7.4. Business Strategies and Development; 9.5.8. Wedgewood Pharmacy; 9.5.8.1. Company Overview; 9.5.8.2. Product Portfolio; 9.5.8.3. Financial Overview; 9.5.8.4. Business Strategies and Development; 9.5.9. Millers Pharmacy; 9.5.9.1. Company Overview; 9.5.9.2. Product Portfolio; 9.5.9.3. Financial Overview; 9.5.9.4. Business Strategies and Development; 9.5.10. Chiron Compounding Pharmacy; 9.5.10.1. Company Overview; 9.5.10.2. Product Portfolio; 9.5.10.3. Financial Overview; 9.5.10.4. Business Strategies and Development
10. Appendix: 10.1. Research Methodology; 10.2. Report Assumptions; 10.3. Acronyms and Abbreviations